Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People’s Republic of China: a comparison with international studies

References

• United NationsWorld Contraceptive Patterns2013Department of Economic and Social Affairs, Population Division Available from: http://www.un.org/en/development/desa/population/publications/pdf/family/worldContraceptivePatternsWallChart2013.pdfAccessed May 20, 2014
   Google Scholar
• Goodyear-SmithFAArrollBContraception before and after termination of pregnancy: can we do it better?N Z Med J20031161186U68314657966
   PubMedGoogle Scholar
• WiebeERSentLFongSChanJBarriers to use of oral contraceptives in ethnic Chinese women presenting for abortionContraception200265215916311927119
   PubMed Web of Science ®Google Scholar
• WuLA survey on the knowledge, attitude, and behavior regarding contraception use among pregnant teenagers in Beijing, ChinaClin Nurs Res201019440341520656920
   PubMed Web of Science ®Google Scholar
• SulakPJKuehlTJOrtizMShullBLAcceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptomsAm J Obstet Gynecol200218661142114912066088
   PubMed Web of Science ®Google Scholar
• WillisSAKuehlTJSpiekermanAMSulakPJGreater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free intervalContraception200674210010316860046
   PubMed Web of Science ®Google Scholar
• SullivanHFurnissHSponaJElsteinMEffect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activityFertil Steril199972111512010428158
   PubMed Web of Science ®Google Scholar
• SponaJElsteinMFeichtingerWShorter pill-free interval in combined oral contraceptives decreases follicular developmentContraception199654271778842582
   PubMed Web of Science ®Google Scholar
• KlippingCDuijkersITrummerDMarrJSuppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimenContraception20087811625
   Web of Science ®Google Scholar
• BachmannGSulakPJSampson-LandersCBendaNMarrJEfficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenoneContraception200470319119815325887
   PubMed Web of Science ®Google Scholar
• KoltunWLuckyAWThiboutotDEfficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trialContraception200877424925618342647
   PubMed Web of Science ®Google Scholar
• MaloneyJMDietzePJrWatsonDTreatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trialObstet Gynecol2008112477378118827119
   PubMed Web of Science ®Google Scholar
• PearlsteinTBBachmannGAZacurHAYonkersKATreatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulationContraception200572641442116307962
   PubMed Web of Science ®Google Scholar
• YonkersKABrownCPearlsteinTBEfficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorderObstet Gynecol2005106349250116135578
   PubMed Web of Science ®Google Scholar
• DingerJBardenheuerKHeinemannKCardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral ContraceptivesContraception201489425326324576793
   PubMed Web of Science ®Google Scholar
• BlodeHKowalKRothKReifSPharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese womenEur J Contracept Reprod Health Care201217428429722680989
   PubMed Web of Science ®Google Scholar
• ZhangGYLinTSunQNAn oral contraceptive containing ethinyl estradiol and drospirenone for the treatment of women with moderate acne vulgaris: a randomized, multicenter, placebo-controlled clinical trialChin J Dermatol20154828589
   Google Scholar
• CaiyanWWenDQinpingLEfficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 microg in a 24+4-day regimen in ChinaZhonghua Fu Chan Ke Za Zhi2014495355359 Chinese25030732
   PubMedGoogle Scholar
• FuYMiW-FZhangH-YThe efficacy and safety of YAZ in the treatment of PMDD: a randomized, double blind placebo-controlled studyZhonghua Fu Chan Ke Za Zhi2014497506509 Chinese25327732
   PubMedGoogle Scholar
• HernádiLMarrJTrummerDDe LeoVPetragliaFEfficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimenContraception2009801182419501211
   PubMed Web of Science ®Google Scholar
• GollnickHCurrent concepts of the pathogenesis of acne: implications for drug treatmentDrugs200363151579159612887264
   PubMed Web of Science ®Google Scholar
• ShawJCAcne: effect of hormones on pathogenesis and managementAm J Clin Dermatol20023857157812358558
   PubMedGoogle Scholar
• ThiboutotDChenWUpdate and future of hormonal therapy in acneDermatology20032061576712566806
   PubMed Web of Science ®Google Scholar
• ThiboutotDMAcne. An overview of clinical research findingsDermatol Clin1997151971099001864
   PubMed Web of Science ®Google Scholar
• MurphyACroppCSSmithBSBurkmanRTZacurHAEffect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute womenFertil Steril199053135392136834
   PubMed Web of Science ®Google Scholar
• van der VangeNBlankensteinMAKloosterboerHJHaspelsAAThijssenJHEffects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosteroneContraception19904143453522139843
   PubMed Web of Science ®Google Scholar
• KoltunWMaloneyJMMarrJKunzMTreatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 mug plus drospirenone 3 mg administered in a 24/4 regimen: a pooled analysisEur J Obstet Gynecol Reprod Biol2011155217117521288628
   PubMed Web of Science ®Google Scholar
• ArowojoluAOGalloMFLopezLMGrimesDACombined oral contraceptive pills for treatment of acneCochrane Database Syst Rev20127CD004425
   PubMedGoogle Scholar
• WittchenHUBeckerELiebRKrausePPrevalence, incidence and stability of premenstrual dysphoric disorder in the communityPsychol Med200232111913211883723
   PubMed Web of Science ®Google Scholar
• HalbreichUBorensteinJPearlsteinTKahnLSThe prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)Psychoneuroendocrinology200328Suppl 3123
   Google Scholar
• SchmidtPJNiemanLKDanaceauMAAdamsLFRubinowDRDifferential behavioral effects of gonadal steroids in women with and in those without premenstrual syndromeN Engl J Med199833842092169435325
   PubMed Web of Science ®Google Scholar
• HahnPMVan VugtDAReidRLA randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndromePsychoneuroendocrinology19952021932097899538
   PubMed Web of Science ®Google Scholar
• BrownCSLingFWAndersenRNFarmerRGArheartKLEfficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trialObstet Gynecol19948457797867936512
   PubMed Web of Science ®Google Scholar
• HylanTRSundellKJudgeRThe impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and FranceJ Womens Health Gend Based Med1999881043105210565662
   PubMed Web of Science ®Google Scholar
• EndicottJNeeJHarrisonWDaily Record of Severity of Problems (DRSP): reliability and validityArch Womens Ment Health200691414916172836
   PubMed Web of Science ®Google Scholar
• WuLHeZZhaoHChinese version of Daily Record of Severity of Problems: reliability and validityJ Adv Nurs201369244945622737971
   PubMed Web of Science ®Google Scholar
• GrimesDASchulzKFNonspecific side effects of oral contraceptives: nocebo or noise?Contraception20118315921134497
   PubMed Web of Science ®Google Scholar